A phase 1 study of triplet therapy with navitoclax, venetoclax, and decitabine for high-risk myeloid malignancies
NOT ENROLLING
Trial ID:
NCT05455294 Protocol # :
22-263
Phase
I
Disease Sites
Other Hematopoietic
Myeloid and Monocytic Leukemia
Principal Investigator
Garcia, Jacqueline, S
Site Research Nurses
Bright, Susan
Logan, Emma, Kristen
Maciejewski, Ashley, Taylor
Smith, Caitlin
Tichon, Jennifer
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #22-263
22-263